Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company

A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a matter of days.

STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at statnews.com →

More in Health & Medicine

More from Tuesday 8 September →